Officers & Directors Detail
Safeguard Scientifics Inc (SFE) (NYSE Arca)
Datin, James
Brief Biography
Mr. Datin joined Safeguard Scientifics, Inc. as Executive Vice President and Managing Director, Life Sciences Group in September 2005. Mr. Datin served as Chief Executive Officer of Touchpoint Solutions, Inc., a provider of software that enables customers to develop and deploy applications, content and media on multi-user interactive devices, from December 2004 to June 2005; Group President in 2004, and as Group President, International, from 2001 to 2003, of Dendrite International, a provider of sales, marketing, clinical and compliance solutions and services to global pharmaceutical and other life sciences companies; and Group Director, Corporate Business Strategy and Planning at GlaxoSmithKline, from 1999 to 2001, where he also was a member of the company’s Predictive Medicine Board of Directors that evaluated acquisitions and alliances. His prior experience also includes international assignments with and identifying strategic growth opportunities for E Merck and Baxter. Mr. Datin is a Director of Clarient, Inc.
Basic Compensation
| Total Annual Compensation, USD | Long-Term Incentive Plans, USD | All Other, USD | Fiscal Year Total, USD |
|---|---|---|---|
| 503,100 | -- | 401,375 | 904,475 |
Options Compensation
| Quantity | Value | ||
|---|---|---|---|
| Excercisable | -- | Market Value | -- |
| Unexercisable | 2,000,000 | Market Value | 740,000.00 |
| Excercised | -- | Market Value | -- |

